Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
All claims against the company in the litigation have now been dismissed.
Subscribe To Our Newsletter & Stay Updated
